The upregulated expression of FXR in the ileum, when compared to the colon in IBD patients and HIs, is consistent with the findings of Inagaki et al., who reported the greater mRNA expression of this receptor in the ileum of mice when compared to other intestinal sites [45]. The gene discussed is NR1H4; the disease is inflammatory bowel disease.